DAXCERB Trademark

Trademark Overview

On Wednesday, May 11, 2022, a trademark application was filed for DAXCERB with the United States Patent and Trademark Office. The USPTO has given the DAXCERB trademark a serial number of 97406501. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Saturday, March 15, 2025. This trademark is owned by Pfizer Inc.. The DAXCERB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
daxcerb

General Information

Serial Number97406501
Word MarkDAXCERB
Filing DateWednesday, May 11, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateSaturday, March 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Saturday, May 14, 2022NEW APPLICATION ENTERED
Tuesday, May 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 4, 2023ASSIGNED TO EXAMINER
Wednesday, January 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 5, 2023SOU EXTENSION 1 FILED
Tuesday, September 5, 2023SOU EXTENSION 1 GRANTED
Thursday, September 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 4, 2024SOU EXTENSION 2 FILED
Monday, March 4, 2024SOU EXTENSION 2 GRANTED
Tuesday, March 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2024SOU EXTENSION 3 GRANTED
Friday, August 30, 2024SOU EXTENSION 3 FILED
Tuesday, March 4, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 14, 2025SOU TEAS EXTENSION RECEIVED
Saturday, March 15, 2025SOU EXTENSION 4 FILED
Saturday, March 15, 2025SOU EXTENSION 4 GRANTED
Saturday, March 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

daxcerb preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone